Perhaps but if the market perception is the payout will be lessened, even if in reality it probably won't, biotech is going to pull back. Perhaps only temporary and a buying opp but pullback nonetheless.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.